Financial Statements — PHVS
Balance Sheet
(in millions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Cash & Equivalents | 199.57 | 343.57 | 179.19 | 201.38 |
| Total Assets | 209.81 | 351.85 | 189.74 | 206.74 |
| Total Liabilities | 25.47 | 19.08 | 16.01 | 16.17 |
| Retained Earnings | (494.94) | (324.77) | (208.86) | (116.24) |
| Total Stockholder Equity | 184.34 | 332.77 | 173.73 | 190.57 |
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Research & Development | 29.61 | 23.07 | 14.68 | 13.72 |
| Selling, General & Admin | 10.77 | 11.31 | 7.77 | 7.66 |
| Total Operating Expenses | 40.37 | 34.38 | 22.46 | 21.38 |
| Operating Income | (45.28) | (29.66) | (21.80) | (9.88) |
| Pretax Income | (91.32) | (57.39) | (44.37) | (25.87) |
| Tax Provision | 0.20 | 0.07 | 0.09 | 2.74 |
| Net Income | (45.48) | (29.73) | (21.90) | (12.62) |
| Basic EPS | (0.83) | (0.55) | (0.63) | (0.38) |
| Diluted EPS | (0.83) | (0.55) | (0.63) | (0.38) |
Cash Flow Statement
(in millions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Operating Cash Flow | (68.45) | (51.91) | (45.69) | (31.57) |
| Investing Cash Flow | (0.14) | (0.07) | (0.05) | (0.05) |
| Financing Cash Flow | (0.10) | 1.12 | 63.78 | 8.82 |
